Legendary investor Louis Navellier, who has spent nearly five decades building quantitative systems, believes AI may be the biggest advancement he has seen in his career and that it is poised to reshape investing. He revisited the “eureka moment” that launched his career and shared why a new collaboration with TradeSmith has him more excited than anything he has seen in decades. During a presentation with TradeSmith CEO Keith Kaplan, they demonstrated how AI can help investors become more tactical in volatile markets. Separately, the article notes that Demis Hassabis, the founder of DeepMind, won the 2024 Nobel Prize in Chemistry for building an AI model called AlphaFold2 that mapped virtually all 200 million known proteins, touching off a revolution in drug discovery. Hassabis estimates we will cure ALL disease within 10 years. Recent medical advances include a drug that doubled survival in pancreatic cancer, a one-time gene-editing infusion that permanently cut bad cholesterol by 62% from a single dose, and a lung cancer pill that held back a spreading tumor for five full years.